TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.

TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.

OBJECTIVE: We aimed to see if structured treatment interruption (STI) could be supported safely with the use of two cycles of IL-2 (4.5 MIU q12h subcutaneously 5 days) before STI to prolong the time before therapy restarted. METHODS: Subjects were randomly allocated to either A - continuous ART; B -...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Angus, B, Lampe, F, Tambussi, G, Duvivier, C, Katlama, C, Youle, M, Williams, I, Clotet, B, Fisher, M, Post, F, Babiker, A, Phillips, A
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2008

समान संसाधन

Prescribing and using self-injectable antiretrovirals: How concordant are physician and patient perspectives?
द्वारा: Cohen Calvin, और अन्य
प्रकाशित: (2009-02-01)

Interruption of antiretroviral therapy is associated with increased plasma cystatin C.
द्वारा: Mocroft, A, और अन्य
प्रकाशित: (2009)

Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial.
द्वारा: Holodniy, M, और अन्य
प्रकाशित: (2011)

Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption.
द्वारा: Yang, H, और अन्य
प्रकाशित: (2009)

Predictors of SIV recrudescence following antiretroviral treatment interruption
द्वारा: Mykola Pinkevych, और अन्य
प्रकाशित: (2019-10-01)

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
द्वारा: Hurst, J, और अन्य
प्रकाशित: (2015)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
द्वारा: Gossez, M, और अन्य
प्रकाशित: (2018)

Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward.
द्वारा: Abbas, U, और अन्य
प्रकाशित: (2002)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
द्वारा: Dubrocq G, और अन्य
प्रकाशित: (2018-06-01)

Short-course antiretroviral therapy in primary HIV infection.
द्वारा: Fidler, S, और अन्य
प्रकाशित: (2013)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
द्वारा: Evelyn Y. Bonney, और अन्य
प्रकाशित: (2021-03-01)

Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial
द्वारा: Jasmini Alagaratnam, और अन्य
प्रकाशित: (2024-06-01)

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
द्वारा: Lewis, J, और अन्य
प्रकाशित: (2017)

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
द्वारा: Touloumi, G, और अन्य
प्रकाशित: (2006)

Preventing antiretroviral treatment interruptions among HIV/AIDS patients in Africa.
द्वारा: Edward J Mills, और अन्य
प्रकाशित: (2013-01-01)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
द्वारा: Samual A. Garner, और अन्य
प्रकाशित: (2017-04-01)

Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).
द्वारा: Pett, S, और अन्य
प्रकाशित: (2011)

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy
द्वारा: Stöhr, W, और अन्य
प्रकाशित: (2013)

DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus.
द्वारा: Melanie Thompson, और अन्य
प्रकाशित: (2016-01-01)

Unplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these?
द्वारा: Lalloo David, और अन्य
प्रकाशित: (2010-03-01)

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy.
द्वारा: Wolfgang Stöhr, और अन्य
प्रकाशित: (2013-01-01)

Interleukin 2 treatment in HIV-1 infection.
द्वारा: Angus, B
प्रकाशित: (2006)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
द्वारा: Pasquale Santangeli, और अन्य
प्रकाशित: (2011-01-01)

Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV
द्वारा: A.L. Hill, और अन्य
प्रकाशित: (2015-12-01)

Factors Affecting Virological Outcome When First-Line Antiretroviral Therapy Is Reintroduced After Unplanned Interruption
द्वारा: Suzy Maria MD, और अन्य
प्रकाशित: (2020-01-01)

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.
द्वारा: Alison L Hill, और अन्य
प्रकाशित: (2016-04-01)

Immunological predictors of CD4<sup>+ </sup>T cell decline in antiretroviral treatment interruptions
द्वारा: Gonzalez-García Juan, और अन्य
प्रकाशित: (2008-02-01)

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome
द्वारा: Bruna Oriol-Tordera, और अन्य
प्रकाशित: (2022-04-01)

mSphere of Influence: Whole-Genome Sequencing, a Vital Tool for the Interruption of Nosocomial Transmission
द्वारा: Ahmed Babiker
प्रकाशित: (2021-04-01)

Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
द्वारा: Gondim, MVP, और अन्य
प्रकाशित: (2021)

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015
द्वारा: Churchill, D, और अन्य
प्रकाशित: (2016)

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals.
द्वारा: Katherine E Clarridge, और अन्य
प्रकाशित: (2018-01-01)

Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
द्वारा: Llibre JM, और अन्य
प्रकाशित: (2013-05-01)

Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption
द्वारा: You Park, और अन्य
प्रकाशित: (2017-11-01)

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection
द्वारा: Deeks Steven G, और अन्य
प्रकाशित: (2005-08-01)

Cortical structural changes related to early antiretroviral therapy (ART) interruption in perinatally HIV-infected children at 5 years of age
द्वारा: Emmanuel C. Nwosu, और अन्य
प्रकाशित: (2021-06-01)

Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV.
द्वारा: Boutboul, F, और अन्य
प्रकाशित: (2005)

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
द्वारा: Hadega A Aamer, और अन्य
प्रकाशित: (2020-08-01)

Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model.
द्वारा: Rebecca Arden Harris, और अन्य
प्रकाशित: (2018-01-01)

PP 4.11 – 00126 Autologous Neutralizing Antibodies Increase with Early Antiretroviral Therapy and Shape HIV Rebound after Treatment Interruption
द्वारा: E. Esmaeilzadeh, और अन्य
प्रकाशित: (2022-12-01)